FIELD: medicine.
SUBSTANCE: therapeutic nutrient composition containing a mix of dihydroquercetin, sodium alginate and ascorbic acid taken in certain mixture ratio.
EFFECT: composition possesses the improved antidiabetic, hypoglycaemic, hypolipidemic, antihypertensive, antiadipogenic, anti-inflammatory and antioxidant properties.
3 cl, 10 dwg, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIOXIDANT LIPOSOMAL COMPOSITION FIR INHALATION IN LUNG AND UPPER RESPIRATORY TRACT DISEASES | 2006 |
|
RU2315593C1 |
| EDARAVON COMBINATION FOR TREATING ISCHEMIC BRAIN INJURY | 2017 |
|
RU2693627C2 |
| PHARMACEUTICAL COMPOSITION POSSESSING EXHIBITING PROPERTY OF ENDOTHELIAL DYSFUNCTION REDUCTION ACCOMPANYING CARDIOVASCULAR DISEASES | 2011 |
|
RU2505290C2 |
| METHOD OF FEEDING YOUNG PIGS DURING THE FATTENING PERIOD | 2022 |
|
RU2804619C1 |
| METHOD OF PRODUCING DAIRY CONCENTRATE WITH LICOPINE AND METHOD FOR CONTROLLING IT IN CONCENTRATE | 1997 |
|
RU2136166C1 |
| VITALARIX CARDIO BIOLOGICALLY ACTIVE SUPPLEMENT | 2007 |
|
RU2357746C2 |
| EYE MEDICINAL FILM WITH MOXIFLOXACIN | 2015 |
|
RU2581025C1 |
| COMPLEX AGENT FOR ALCOHOL WITHDRAWAL AND HEPATOPROTECTIVE ACTION RELIEF | 2019 |
|
RU2739187C2 |
| METHOD OF AGENT APPLICATION BASED ON HUMAN MODIFIED PEROXYREDOXIN 2 FOR CORRECTING CONSEQUENCES OF ISCHEMIC-REPERFUSIVE KIDNEY DAMAGE | 2020 |
|
RU2747121C1 |
| AGENT POSSESSING LYMPHOKINETIC ACTIVITY | 2014 |
|
RU2560518C1 |
